2009 PUBLICATIONS

1. Johanson CE, Balster RL, Henningfield JE, Schuster CR, Anthony JC, Barthwell
   AG, Coleman JJ, Dart RC, Gorodetzky CW, O'Keeffe C, Sellers EM, Vocci F, Walsh
   SL. Risk management and post-marketing surveillance for the abuse of medications
   acting on the central nervous system: expert panel report. Drug Alcohol Depend.
   2009 Dec 1;105 Suppl 1:S65-71. Epub 2009 Sep 23. PubMed PMID: 19783383; PubMed
   Central PMCID: PMC2844248.

2. Al Koudsi N, Ahluwalia JS, Lin SK, Sellers EM, Tyndale RF. A novel CYP2A6
   allele (CYP2A6*35) resulting in an amino-acid substitution (Asn438Tyr) is
   associated with lower CYP2A6 activity in vivo. Pharmacogenomics J. 2009
   Aug;9(4):274-82. Epub 2009 Apr 14. PubMed PMID: 19365400; PubMed Central PMCID:
   PMC2922203.

3. Mwenifumbo JC, Sellers EM, Tyndale RF. Nicotine metabolism and CYP2A6
   activity in a population of black African descent: impact of gender and light
   smoking. Drug Alcohol Depend. 2007 Jun 15;89(1):24-33. Epub 2006 Dec 8. Erratum
   in: Drug Alcohol Depend. 2009 Sep 1;104(1-2):185. PubMed PMID: 17161559.

PUBLICATIONS ARCHIVE